{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:00:54Z","timestamp":1790848854839,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["72074123"],"award-info":[{"award-number":["72074123"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To evaluate the impact of China's National Volume\u2010Based Procurement policy (NVBP) on utilisation and expenditures of antidiabetic drugs, with a focus on insulin, using real\u2010world data from Nanjing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Monthly procurement data from public healthcare facilities in Nanjing were analysed from January 2016 to December 2022. Drug utilisation was measured using the Anatomical Therapeutic Chemical\/defined daily dose (ATC\/DDD) methodology, and expenditures were measured by total spending and defined daily dose cost (DDDc). Linear regression analysis was employed to assess temporal trends, while interrupted time series (ITS) analysis was conducted to evaluate the impact of five policy implementation batches between January 2019 and December 2022 on changes in drug use and spending.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During the 7\u2010year study period, the use of NVBP\u2010related antidiabetic drugs in Nanjing increased significantly, while total expenditures decreased. Before NVBP, expenditures grew annually by 9.1%, but declined by 12.4% per year after policy implementation. Insulin remained the dominant therapy but its utilisation proportion declined by approximately 40%, while metformin and sulfonylurea use increased. Newer antidiabetic drugs saw breakthrough growth post\u2010policy. ITS analyses showed substantial immediate reductions in DDDc across batches, particularly for insulin, with unit costs decreasing by 36.5%. Utilisation responses varied by procurement batch, while domestic insulin products gained market share.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The NVBP was associated with substantial reductions in antidiabetic medicine costs and changes in market structure, while utilisation effects varied across procurement batches. The insulin\u2010focused sixth batch achieved marked price reductions and increased substitution towards domestically produced insulin without increasing overall utilisation. These findings suggest that centralised procurement may improve affordability while reshaping pharmaceutical markets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tmi.70192","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:32:19Z","timestamp":1782952339000},"page":"1483-1493","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antidiabetic Drug Use and Expenditure Trends After National Volume\u2010Based Procurement Policy in Nanjing City: An Interrupted Time\u2010Series Analysis"],"prefix":"10.1111","volume":"31","author":[{"given":"Man","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"},{"name":"Department of Pharmacy, the Second People's Hospital of Changzhou the Third Affiliated Hospital of Nanjing Medical University  Changzhou Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongting","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuying","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoye","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Health Policy, School of Health Policy and Management Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Regulatory Science and Pharmacoeconomics, School of Pharmacy Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-8061","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the Second People's Hospital of Changzhou the Third Affiliated Hospital of Nanjing Medical University  Changzhou Jiangsu China"},{"name":"Department of Health Policy, School of Health Policy and Management Nanjing Medical University  Nanjing Jiangsu China"},{"name":"Center for Global Health, School of Public Health Nanjing Medical University  Nanjing Jiangsu China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"e_1_2_13_2_1","volume-title":"IDF Diabetes Atlas","author":"Magliano D. J.","year":"2021"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1962"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01190-w"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0004"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110983"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czy076"},{"key":"e_1_2_13_9_1","unstructured":"State Council General Office \u201cOpinions on Promoting the Regular and Institutional Development of Centralized Volume\u2010Based Drug Procurement (Guo Ban Fa [2021] No. 2) \u201d2021 https:\/\/www.gov.cn\/gongbao\/content\/2021\/content_5585228.htm."},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.5582\/ddt.2019.01093"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1386533"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1405197"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-054346"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3429"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-023-02006-1"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10917-0"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001987"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/00343404.2015.1101517"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/1468-0009.12507"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czi015"},{"key":"e_1_2_13_21_1","unstructured":"World Health Organization \u201cKeeping the 100\u2010Year\u2010Old Promise: Making Insulin Access Universal \u201d2021 https:\/\/www.who.int\/publications\/i\/item\/9789240039100."},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.2337\/dci18-0019"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jlb\/lsaa061"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.923209"},{"key":"e_1_2_13_25_1","unstructured":"National Healthcare Security Adiministration Department of Pharmaceutical Price and Tender Procurement.Notice on the Reference Monitoring Scope of Substitutable Drugs for the First Seven Batches of the National Centralized Drug Procurement. Yibao jiacai Han [2022] No.126. 2022."},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14117"},{"key":"e_1_2_13_27_1","unstructured":"The WHO Collaborating Centre for Drug Statistics Methodology \u201cImplementation and Maintenance of the ATC\/DDD Methodology \u201d2024 https:\/\/www.whocc.no\/use_of_atc_ddd."},{"key":"e_1_2_13_28_1","unstructured":"Jiangsu Provincial Bureau of Statistic \u201cJiangsu Province Statistic Yearbook \u201daccessed 21 March 2025 https:\/\/tj.jiangsu.gov.cn\/col\/col86293\/index.html."},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/1536867X1701700105"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12874"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003567"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-011535"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15729"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112138-20230305-00131"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12080"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-019-00742-8"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01148-3"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-024-10964-7"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3042"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8510(03)00018-6"},{"key":"e_1_2_13_41_1","article-title":"2024 Annual Drug Evaluation Report Released","volume":"3","author":"Luo N.","year":"2025","journal-title":"China Pharmaceutical News"},{"key":"e_1_2_13_42_1","unstructured":"National Healthcare Security Administration \u201cNational Centralized Drug Procurement Document (Insulin Special Collection) (GY\u2010YD2021\u20103) \u201d2026 https:\/\/www.smpaa.cn\/gjsdcg\/2021\/11\/05\/10361.shtml."},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-014489"}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.70192","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tmi.70192","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tmi.70192","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:32:39Z","timestamp":1790847159000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tmi.70192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/tmi.70192"],"URL":"https:\/\/doi.org\/10.1111\/tmi.70192","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-04-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}